ACHL Latest News, Press Relases and Analysis

All

Press Releases

9 months ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration

a year ago - By: BusinessInsider

ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024

a year ago - By: InvestorPlace

ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024

2 years ago - By: BusinessInsider

ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024

10 months ago - By: Benzinga - Mentions: ICCC AZTR DBVT UPC ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

a year ago - By: Benzinga - Mentions: AZN

Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts

a year ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

a year ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market

a year ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

2 years ago - By: InvestorPlace

ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024

2 years ago - By: BusinessInsider

ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

a year ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Announces Strategic Update

a year ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

2 years ago - By: Achilles Therapeutics PLC - Mentions: ARCT

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

2 years ago - By: InvestorPlace

ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

2 years ago - By: InvestorPlace - Mentions: HWH ZCMD HUBC BROG ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

2 years ago - By: Achilles Therapeutics PLC

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

2 years ago - By: Achilles Therapeutics PLC

ACHILLES THERAPEUTICS PL-ADR (ACHL) Stock News

ACHL Latest News, Press Relases and Analysis